Episode Details

Back to Episodes
Emerging Therapies for Pruritus in PBC

Emerging Therapies for Pruritus in PBC

Episode 422 Published 1 year, 3 months ago
Description

Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients’ quality of life.

Listen as they discuss:

  • Gaps in current management
  • Patient perspectives: why we should not dismiss itching as an underlying psychologic problem
  • PPAR agonists and how they affect pruritus
  • BEZURSO and FITCH 
  • ELATIVE
  • ENHANCE and RESPONSE
  • IBATs (inhibitors of bile acid transport)
  • GLIMMER
  • Common questions

Presenters:

Marlyn J. Mayo, MD
Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Pam Rivard, RN
Person living with PBC

Link to full program: 
https://bit.ly/3Dnfb2E


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us